(P621) One Less Ouch! Managing DKA Through Continuous Monitoring

This quality improvement project introduces continuous glucose monitoring (CGM) for Diabetic Ketoacidosis (DKA) patients in the ICU to enhance glucose control and reduce fingerstick testing. The FDA-approved CGM device has been effective in pediatric ICUs by minimizing manual glucose checks and identifying hypo/hyperglycemia patterns. Through collaboration with CGM manufacturers, a standard operating protocol was developed for pediatric inpatient use. Post-implementation, fingerstick usage decreased, and glucose targets were consistently met. Patient satisfaction surveys showed positive results. This session will discuss the integration of outpatient technology into inpatient care to improve patient outcomes and enhance the overall patient experience in the ICU.